2Hellmann JR, Myer CM, Prenger EC. Therapeutic alternatives in the treatment of life-threatening vasoformatire tumors[J]. Am J Otolaryngol. 1992, 13 (1) :48.
3Orford J, Barker A, Thonell S, et al. Bleomycin therapy for cystic hygroma [ J ]. J Pediatr Surg. 1995, 30(9) : 1282.
4Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics [J]. Plast Reconstr Surg, 1982, 69(3) :412.
5Zulfiqar MA, Zaleha AM, Zakarla Z, et al. The Treatment of neck lymphangioma with intralesional injection of bleomycin [J]. Med J Malaysia, 1999, 54(4) :478.
6Lewis J, Chung RS, Allison J. Sclerotherapy of esophageal varices[J]. Arch Surg, 1980, 115(4) : 476.
7Okada A, Kubota A, Fukuzawa M, et al. Injection of bleomycin as a primary therapy of cystic lymphangioma[J].J Pediatr Surg, 1992, 27(4) :440.
8Zhao J H, Zhao YF, Chen XM, et al. Histological investigation of veins and venous malformations after injection of sclerosing agents [J]. Asian J Oral Maxillofac Surg, 2002, 14(4) :226.
2Impellizzeri P,Romeo C,Borruto FA,et al.Sclerotherapy for cervical cystic lymphaticmal formations in children.Our experience with computed tomography-guided 98% sterile ethanol insertion and a review of the literature[J].J Pediatr Surg,2010,45(12):2473-2478.
3Mulliken JB,Glowacki J.Hemangiomas and vascular malformations in infants and children:a classification based on endothelial characteristics[J].Plast Reeonstr Surg,1982,69(3):412-422.
4Gallagher PG,Mahoney MJ,Gosche JR.Cystic hygroma in the fetus and newborn[J].Semin Perinatol,1999,23(4):341-356.
5Lei ZM,Huang XX,Sun ZJ,et al.Surger of lymphatic malfortamions in oral and cervicofacial regions in children[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2007,104(3):338-344.
6Wang LC,Krunic AL,Medenica MM,et al.Treatment of hemorrhagic lymphatic malformation of the tongue with a pulsed-dyelaser[J].J Am Acad Dermatol,2005,52(6):1088-1090.
9Ernemann U,Kramer U,Miller S,et al.Current concepts in the classification,diagnosis and treatment of vascular anomalies[J].Euro J Radiol,2011,75(1):2-11.
10Karawajczyk A,Buda F.The metal bonding domain of the antitumor drug Fe(Ⅱ)-bleomycin:a DFT investigation[J].J Biol Chem,2005,10(1):33-40.
